Update information

Update information

October 2019: Changes have been made to recommendations 1.9.6, 1.9.9, 1.9.10 and 1.9.11 to reflect new restrictions and precautions for the use of fluoroquinolone antibiotics. These recommendations are labelled [new 2014, amended 2019].

November 2014: recommendation 1.7.7 has been amended to clarify the type of NSAID to be used and that a proton-pump inhibitor should also be prescribed.

September 2014: This guideline updates and replaces NICE guideline CG17 (published in April 2004).

Recommendations are marked as [new 2014], [2014], [2004] or [2004, amended 2014]:

  • [new 2014] indicates that the evidence has been reviewed and the recommendation has been added or updated

  • [2014] indicates that the evidence has been reviewed but no change has been made to the recommended action

  • [2004] indicates that the evidence has not been reviewed since 2004

  • [2004, amended 2014] indicates that the evidence has not been reviewed since 2004, but changes have been made to the recommendation wording that change the meaning.

ISBN: 978-1-4731-0717-5

  • National Institute for Health and Care Excellence (NICE)